Stomatology ›› 2023, Vol. 43 ›› Issue (5): 465-470.doi: 10.13591/j.cnki.kqyx.2023.05.014
• Summary • Previous Articles Next Articles
ZHONG Jiawei1,PAN Jian1,2,GUO Yuchen1,2(
)
Revised:2022-10-26
Online:2023-05-28
Published:2023-05-31
Contact:
GUO Yuchen
E-mail:guoyuchen@scu.edu.cn
CLC Number:
ZHONG Jiawei,PAN Jian,GUO Yuchen. Advances in the regulation of immune cells in jaw homeostasis and damage repair[J]. Stomatology, 2023, 43(5): 465-470.
| [1] |
Peres MA, MacPherson LMD, Weyant RJ, et al. Oral diseases: A global public health challenge[J]. Lancet, 2019, 394(10194):249-260.
doi: S0140-6736(19)31146-8 pmid: 31327369 |
| [2] |
Thrivikraman G, Athirasala A, Twohig C, et al. Biomaterials for craniofacial bone regeneration[J]. Dent Clin North Am, 2017, 61(4):835-856.
doi: S0011-8532(17)30069-1 pmid: 28886771 |
| [3] |
Dar HY, Azam Z, Anupam R, et al. Osteoimmunology: The Nexus between bone and immune system[J]. Front Biosci (Landmark Ed), 2018, 23(3):464-492.
doi: 10.2741/4600 |
| [4] |
Arron JR, Choi Y. Bone versus immune system[J]. Nature, 2000, 408(6812):535-536.
doi: 10.1038/35046196 |
| [5] |
Yoshida H, Hayashi S, Kunisada T, et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene[J]. Nature, 1990, 345(6274):442-444.
doi: 10.1038/345442a0 |
| [6] |
Wiktor-Jedrzejczak W, Bartocci A, Ferrante AW Jr, et al. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse[J]. Proc Natl Acad Sci USA, 1990, 87(12):4828-4832.
doi: 10.1073/pnas.87.12.4828 pmid: 2191302 |
| [7] |
Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation[J]. Cell, 1998, 93(2):165-176.
doi: 10.1016/s0092-8674(00)81569-x pmid: 9568710 |
| [8] | 雷雨田. 脉冲电磁场调节Akt/mTOR信号通路抑制RAW264.7巨噬细胞向破骨细胞分化[D]. 广州: 南方医科大学, 2018. |
| [9] |
Weitzmann MN, Vikulina T, Roser-Page S, et al. Homeostatic expansion of CD4+ T cells promotes cortical and trabecular bone loss, whereas CD8+ T cells induce trabecular bone loss only[J]. J Infect Dis, 2017, 216(9):1070-1079.
doi: 10.1093/infdis/jix444 pmid: 28968828 |
| [10] |
González-Osuna L, Sierra-Cristancho A, Rojas C, et al. Premature senescence of T-cells favors bone loss during osteolytic diseases. A new concern in the osteoimmunologyarena[J]. Aging Dis, 2021, 12(5):1150-1161.
doi: 10.14336/AD.2021.0110 |
| [11] |
Deng ZQ, Zhang Q, Zhao Z, et al. Crosstalk between immune cells and bone cells or chondrocytes[J]. Int Immunopharmacol, 2021, 101(Pt A):108179.
doi: 10.1016/j.intimp.2021.108179 |
| [12] |
Liu HR, Luo TT, Tan JL, et al. ‘osteoimmunology’ offers new perspectives for the treatment of pathological bone loss[J]. Curr Pharm Des, 2017, 23(41):6272-6278.
doi: 10.2174/1381612823666170511124459 |
| [13] |
Weitzmann MN. Bone and the immune system[J]. Toxicol Pathol, 2017, 45(7):911-924.
doi: 10.1177/0192623317735316 pmid: 29046115 |
| [14] |
Takayanagi H, Ogasawara K, Hida S, et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma[J]. Nature, 2000, 408(6812):600-605.
doi: 10.1038/35046102 |
| [15] |
AyonHaro ER, Ukai T, Yokoyama M, et al. Locally administered interferon-γ accelerates lipopolysaccharide-induced osteoclastogenesis independent of immunohistological RANKL upregulation[J]. J Periodontal Res, 2011, 46(3):361-373.
doi: 10.1111/j.1600-0765.2011.01352.x pmid: 21361961 |
| [16] |
Biros E, Malabu UH, Vangaveti VN, et al. The IFN-γ/miniTrpRS signaling axis: An insight into the pathophysiology of osteoporosis and therapeutic potential[J]. Cytokine Growth Factor Rev, 2022, 64: 7-11.
doi: 10.1016/j.cytogfr.2022.01.005 |
| [17] |
Sato K, Suematsu A, Okamoto K, et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction[J]. J Exp Med, 2006, 203(12):2673-2682.
doi: 10.1084/jem.20061775 pmid: 17088434 |
| [18] |
Chen Z, Bozec A, Ramming A, et al. Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis[J]. Nat Rev Rheumatol, 2019, 15(1):9-17.
doi: 10.1038/s41584-018-0109-2 pmid: 30341437 |
| [19] |
Schinocca C, Rizzo C, Fasano S, et al. Role of the IL-23/IL-17 pathway in rheumatic diseases: An overview[J]. Front Immunol, 2021, 12: 637829.
doi: 10.3389/fimmu.2021.637829 |
| [20] | Maeda K, Yoshida K, Nishizawa T, et al. Inflammation and bone metabolism in rheumatoid arthritis: Molecular mechanisms of joint destruction and pharmacological treatments[J]. Int J MolSci, 2022, 23(5):2871. |
| [21] |
Croes M, Öner FC, van Neerven D, et al. Proinflammatory T cells and IL-17 stimulate osteoblast differentiation[J]. Bone, 2016, 84: 262-270.
doi: S8756-3282(16)00011-9 pmid: 26780388 |
| [22] |
Croes M, Kruyt MC, Groen WM, et al. Interleukin 17 enhances bone morphogenetic protein-2-induced ectopic bone formation[J]. Sci Rep, 2018, 8(1):7269.
doi: 10.1038/s41598-018-25564-9 pmid: 29740080 |
| [23] |
Zhang WJ, Dang K, Huai Y, et al. Osteoimmunology: the regulatory roles of T lymphocytes in osteoporosis[J]. Front Endocrinol (Lausanne), 2020, 11: 465.
doi: 10.3389/fendo.2020.00465 |
| [24] |
Li Y, Toraldo G, Li AM, et al. B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo[J]. Blood, 2007, 109(9):3839-3848.
doi: 10.1182/blood-2006-07-037994 |
| [25] |
Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems[J]. Nat Rev Immunol, 2007, 7(4):292-304.
doi: 10.1038/nri2062 pmid: 17380158 |
| [26] |
Hathaway-Schrader JD, Novince CM. Maintaining homeostatic control of periodontal bone tissue[J]. Periodontol 2000, 2021, 86(1):157-187.
doi: 10.1111/prd.v86.1 |
| [27] |
Kong YY, Feige U, Sarosi I, et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerinligand[J]. Nature, 1999, 402(6759):304-309.
doi: 10.1038/46303 |
| [28] |
Nakane S, Imamura K, Hisanaga R, et al. Systemic administration of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4)-Ig abrogates alveolar bone resorption in induced periodontitis through inhibition of osteoclast differentiation and activation: An experimental investigation[J]. J Periodontal Res, 2021, 56(5):972-981.
doi: 10.1111/jre.v56.5 |
| [29] |
Komatsu N, Takayanagi H. Mechanisms of joint destruction in rheumatoid arthritis-immune cell-fibroblast-bone interactions[J]. Nat Rev Rheumatol, 2022, 18(7):415-429.
doi: 10.1038/s41584-022-00793-5 pmid: 35705856 |
| [30] |
Li XY, Xu HH, Huang J, et al. Dysfunctions, molecular mechanisms, and therapeutic strategies of regulatory T cells in rheumatoid arthritis[J]. Front Pharmacol, 2021, 12: 716081.
doi: 10.3389/fphar.2021.716081 |
| [31] | Bozec A, Zaiss MM. T regulatory cells in bone remodelling[J]. CurrOsteoporos Rep, 2017, 15(3):121-125. |
| [32] |
Zhang W, Zhao W, Li W, et al. The imbalance of cytokines and lower levels of tregs in elderly male primary osteoporosis[J]. Front Endocrinol (Lausanne), 2022, 13: 779264.
doi: 10.3389/fendo.2022.779264 |
| [33] |
Fischer L, Herkner C, Kitte R, et al. Foxp3+ regulatory T cells in bone and hematopoietic homeostasis[J]. Front Endocrinol (Lausanne), 2019, 10: 578.
doi: 10.3389/fendo.2019.00578 |
| [34] |
Liu Y, Wang L, Kikuiri T, et al. Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-γ and TNF-Α[J]. Nat Med, 2011, 17(12):1594-1601.
doi: 10.1038/nm.2542 pmid: 22101767 |
| [35] |
Greene AC, Shehabeldin M, Gao J, et al. Local induction of regulatory T cells prevents inflammatory bone loss in ligature-induced experimental periodontitis in mice[J]. Sci Rep, 2022, 12(1):5032.
doi: 10.1038/s41598-022-09150-8 pmid: 35322204 |
| [36] |
Fan X, Chi GH, Yan L, et al. Treg-promoted new bone formation through suppressing TH17 by secreting interleukin-10 in ankylosing spondylitis[J]. Spine, 2019, 44(23):E1349-E1355.
doi: 10.1097/BRS.0000000000003169 |
| [37] |
Li J, Yu TT, Yan HC, et al. T cells participate in bone remodeling during the rapid palatal expansion[J]. FASEB J, 2020, 34(11):15327-15337.
doi: 10.1096/fsb2.v34.11 |
| [38] |
Alvarez C, Suliman S, Almarhoumi R, et al. Regulatory T cell phenotype and anti-osteoclastogenic function in experimental periodontitis[J]. Sci Rep, 2020, 10(1):19018.
doi: 10.1038/s41598-020-76038-w pmid: 33149125 |
| [39] |
Komatsu N, Okamoto K, Sawa S, et al. Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis[J]. Nat Med, 2014, 20(1):62-68.
doi: 10.1038/nm.3432 pmid: 24362934 |
| [40] |
Wang YN, Liu SY, Jia TT, et al. T cell protein tyrosine phosphatase in osteoimmunology[J]. Front Immunol, 2021, 12: 620333.
doi: 10.3389/fimmu.2021.620333 |
| [41] |
Sun W, Meednu N, Rosenberg A, et al. B cells inhibit bone formation in rheumatoid arthritis by suppressing osteoblast differentiation[J]. Nat Commun, 2018, 9(1):5127.
doi: 10.1038/s41467-018-07626-8 pmid: 30510188 |
| [42] |
Han YK, Jin Y, Miao YB, et al. Improved RANKL expression and osteoclastogenesis induction of CD27+CD38-memory B cells: A link between B cells and alveolar bone damage in periodontitis[J]. J Periodontal Res, 2019, 54(1):73-80.
doi: 10.1111/jre.2019.54.issue-1 |
| [43] |
Deshet-Unger N, Kolomansky A, Ben-Califa N, et al. Erythropoietin receptor in B cells plays a role in bone remodeling in mice[J]. Theranostics, 2020, 10(19):8744-8756.
doi: 10.7150/thno.45845 pmid: 32754275 |
| [44] |
Pereira M, Petretto E, Gordon S, et al. Common signalling pathways in macrophage and osteoclast multinucleation[J]. J Cell Sci, 2018, 131(11):jcs216267.
doi: 10.1242/jcs.216267 |
| [45] | Yang DH, Yang MY. The role of macrophage in the pathogenesis of osteoporosis[J]. Int J MolSci, 2019, 20(9):2093. |
| [46] |
Zhao DW, Ren B, Wang HW, et al. 3D-printed titanium implant combined with interleukin 4 regulates ordered macrophage polarization to promote bone regeneration and angiogenesis[J]. Bone Joint Res, 2021, 10(7):411-424.
doi: 10.1302/2046-3758.107.BJR-2020-0334.R4 |
| [47] |
Trout KL, Holian A. Factors influencing multinucleated giant cell formationin vitro[J]. Immunobiology, 2019, 224(6):834-842.
doi: 10.1016/j.imbio.2019.08.002 |
| [48] |
Dou C, Ding N, Zhao CR, et al. Estrogen deficiency-mediated M2 macrophage osteoclastogenesis contributes to M1/M2 ratio alteration in ovariectomized osteoporotic mice[J]. J Bone Miner Res, 2018, 33(5):899-908.
doi: 10.1002/jbmr.3364 pmid: 29281118 |
| [49] |
Srivastava RK, Dar HY, Mishra PK. Immunoporosis: Immunology of osteoporosis-role of T cells[J]. Front Immunol, 2018, 9: 657.
doi: 10.3389/fimmu.2018.00657 pmid: 29675022 |
| [50] |
Jung YK, Kang YM, Han S. Osteoclasts in the inflammatory arthritis: Implications for pathologic osteolysis[J]. Immune Netw, 2019, 19(1):e2.
doi: 10.4110/in.2019.19.e2 |
| [51] |
Kaplanski G. Interleukin-18: Biologicalproperties and role in disease pathogenesis[J]. Immunol Rev, 2018, 281(1):138-153.
doi: 10.1111/imr.12616 pmid: 29247988 |
| [52] | Yasuda K, Nakanishi K, Tsutsui H. Interleukin-18 in health and disease[J]. Int J MolSci, 2019, 20(3):649. |
| [53] |
Tao ZB, Wang JP, Wen KC, et al. Pyroptosis in osteoblasts: A novel hypothesis underlying the pathogenesis of osteoporosis[J]. Front Endocrinol (Lausanne), 2021, 11: 548812.
doi: 10.3389/fendo.2020.548812 |
| [54] | Ni FF, Zhang T, Xiao WN, et al. IL-18-mediated SLC7A5 overexpression enhances osteogenic differentiation of human bone marrow mesenchymal stem cells via the c-MYC pathway[J]. Front Cell DevBiol, 2021, 9: 748831. |
| [55] |
Harmer D, Falank C, Reagan MR. Interleukin-6 interweaves the bone marrow microenvironment, bone loss, and multiple myeloma[J]. Front Endocrinol, 2019, 9: 788.
doi: 10.3389/fendo.2018.00788 |
| [56] |
Han L, Chen Z, Yu K, et al. Interleukin 27 signaling in rheumatoid arthritis patients: Good or evil?[J]. Front Immunol, 2022, 12: 787252.
doi: 10.3389/fimmu.2021.787252 |
| [57] |
Li XH, Luo W, Hu JX, et al. Interleukin-27 prevents LPS-induced inflammatory osteolysis by inhibiting osteoclast formation and function[J]. Am J Transl Res, 2019, 11(3):1154-1169.
pmid: 30972153 |
| [58] |
Pajarinen J, Lin T, Gibon E, et al. Mesenchymal stem cell-macrophage crosstalk and bone healing[J]. Biomaterials, 2019, 196: 80-89.
doi: S0142-9612(17)30834-7 pmid: 29329642 |
| [59] |
Sinder BP, Pettit AR, McCauley LK. Macrophages: their emerging roles in bone[J]. J Bone Miner Res, 2015, 30(12):2140-2149.
doi: 10.1002/jbmr.2735 pmid: 26531055 |
| [60] |
Huang J, Zhou Y, Wang Y, et al. The mutual effects between macrophages and cartilage templates in the process of subcutaneous endochondral bone formation[J]. RSC Adv, 2018, 8(42):23679-23687.
doi: 10.1039/c8ra04463e pmid: 35540265 |
| [61] |
Michalski MN, McCauley LK. Macrophages and skeletal health[J]. Pharmacol Ther, 2017, 174: 43-54.
doi: 10.1016/j.pharmthera.2017.02.017 |
| [62] |
Raggatt LJ, Wullschleger ME, Alexander KA, et al. Fracture healing via periosteal callus formation requires macrophages for both initiation and progression of early endochondralossification[J]. Am J Pathol, 2014, 184(12):3192-3204.
doi: 10.1016/j.ajpath.2014.08.017 pmid: 25285719 |
| [63] |
Yang N, Liu Y. The role of the immune microenvironment in bone regeneration[J]. Int J Med Sci, 2021, 18(16):3697-3707.
doi: 10.7150/ijms.61080 pmid: 34790042 |
| [64] |
Vi L, Baht GS, Whetstone H, et al. Macrophages promote osteoblastic differentiation in-vivo: Implications in fracture repair and bone homeostasis[J]. J Bone Miner Res, 2015, 30(6):1090-1102.
doi: 10.1002/jbmr.2422 |
| [65] |
Shukla P, Mansoori MN, Singh D. Efficacy of anti-IL-23 monotherapy versus combination therapy with anti-IL-17 in estrogen deficiency induced bone loss conditions[J]. Bone, 2018, 110: 84-95.
doi: S8756-3282(18)30049-8 pmid: 29414600 |
| [66] | Shukla P, Mansoori MN, Kakaji M, et al. Interleukin 27 (IL-27) alleviates bone loss in estrogen-deficient conditions by induction of early growth response-2 gene[J]. J BiolChem, 2017, 292(11):4686-4699. |
| [67] |
Vi L, Baht GS, Soderblom EJ, et al. Macrophage cells secrete factors including LRP1 that orchestrate the rejuvenation of bone repair in mice[J]. Nat Commun, 2018, 9(1):5191.
doi: 10.1038/s41467-018-07666-0 pmid: 30518764 |
| [68] |
Heymann D, Rousselle AV. gp130 Cytokine family and bone cells[J]. Cytokine, 2000, 12(10):1455-1468.
pmid: 11023660 |
| [69] |
Feng XM, Shen SL, Cao PP, et al. The role of oncostatin M regulates osteoblastic differentiation of dental pulp stem cells through STAT3 pathway[J]. Cytotechnology, 2016, 68(6):2699-2709.
pmid: 27376650 |
| [70] |
Wang JS, Zheng ZY, Huang B, et al. Osteal tissue macrophages are involved in endplate osteosclerosis through the OSM-STAT3/YAP1 signaling axis in modicchanges[J]. J Immunol, 2020, 205(4):968-980.
doi: 10.4049/jimmunol.1901001 |
| [71] | Cai BL, Lin D, Li Y, et al. N2-polarized neutrophils guide bone mesenchymal stem cell recruitment and initiate bone regeneration: A missing piece of the bone regeneration puzzle[J]. AdvSci (Weinh), 2021, 8(19):e2100584. |
| [72] | Zhao J, Zhao Q, Ning P, et al. G-CSF inhibits growths of osteoblasts and osteocytes by upregulating nitric oxide production in neutrophils[J]. J CraniofacSurg, 2019, 30(8):e776-e780. |
| [73] |
Li CJ, Xiao Y, Sun YC, et al. Senescent immune cells release grancalcin to promote skeletal aging[J]. Cell Metab, 2021, 33(10):1957-1973.e6.
doi: 10.1016/j.cmet.2021.08.009 |
| [74] |
Ng CW, Chan BCL, Ko CH, et al. Human mast cells induce osteoclastogenesis through cell surface RANKL[J]. Inflamm Res, 2022, 71(10/11):1261-1270.
doi: 10.1007/s00011-022-01608-9 |
| [75] |
Kroner J, Kovtun A, Kemmler J, et al. Mast cells are critical regulators of bone fracture-induced inflammation and osteoclast formation and activity[J]. J Bone Miner Res, 2017, 32(12):2431-2444.
doi: 10.1002/jbmr.3234 pmid: 28777474 |
| [76] |
Fischer V, Haffner-Luntzer M. Interaction between bone and immune cells: Implications for postmenopausal osteoporosis[J]. Semin Cell Dev Biol, 2022, 123: 14-21.
doi: 10.1016/j.semcdb.2021.05.014 |
| [77] |
Zhang LZ, Wang T, Chang M, et al. Teriparatide treatment improves bone defect healing via anabolic effects on new bone formation and non-anabolic effects on inhibition of mast cells in a murine cranial window model[J]. J Bone Miner Res, 2017, 32(9):1870-1883.
doi: 10.1002/jbmr.v32.9 |
| [78] | Maximiano WMA, da Silva EZM, Santana AC, et al. Mast cell mediators inhibit osteoblastic differentiation and extracellular matrix mineralization[J]. J HistochemCytochem, 2017, 65(12):723-741. |
| [79] |
Lind T, Melo FR, Gustafson AM, et al. Mast cell chymase has a negative impact on human osteoblasts[J]. Matrix Biol, 2022, 112: 1-19.
doi: 10.1016/j.matbio.2022.07.005 |
| [80] |
Lin WM, Li QW, Zhang DT, et al. Mapping the immune microenvironment for mandibular alveolar bone homeostasis at single-cell resolution[J]. Bone Res, 2021, 9(1):17.
doi: 10.1038/s41413-021-00141-5 pmid: 33723232 |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
